Independent Financial Group’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Independent Financial Group’s Portfolio IBBJ Stock Details IBBJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,275	Closed	-$358K	–	849
2021 Q3	$358K	Buy	+12,275	New	+$374K	0.04%	467

Independent Financial Group's IBBJ Position: Q4 2021 in Review

Independent Financial Group sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 12,275 shares — an estimated $358K sold.

Independent Financial Group first reported a position in IBBJ in Q3 2021 and held it in 1 quarter. The position peaked at $358K in Q3 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

Independent Financial Group reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Independent Financial Group sold 12,275 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $358K.
Independent Financial Group first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q3 2021 and held it in 1 quarter.
Independent Financial Group's Defiance Nasdaq Junior Biotechnology ETF position peaked at $358K in Q3 2021.
0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on Independent Financial Group's 13F filing for Q4 2021, filed 15 Jun 2026.